Job Description
ABOUT VERRICA PHARMACEUTICALS
At Verrica Pharmaceuticals, we are passionate about developing and commercializing medications for the treatment of dermatological diseases, including skin cancers. Our lead product, YCANTH® (cantharidin), is the first and only healthcare professional-administered treatment approved by the FDA to treat patients two years of age and older with molluscum contagiosum - a common, highly contagious skin disease that effects an estimated six million people in the United States, primarily children. Verrica is also currently exploring a Phase 3 program to study its injectable oncolytic peptide, VP-315, for the treatment of basal cell carcinoma, the most common form of skin cancer, and has initiated a global Phase 3 program to study VP-102 (YCANTH®) for the treatment of Common Warts. If you want to work in an environment that uses your unique skills and abilities in a fast-paced, small-pharma environment, we're the team for you!
POSITION SUMMARY
As an Inst...
At Verrica Pharmaceuticals, we are passionate about developing and commercializing medications for the treatment of dermatological diseases, including skin cancers. Our lead product, YCANTH® (cantharidin), is the first and only healthcare professional-administered treatment approved by the FDA to treat patients two years of age and older with molluscum contagiosum - a common, highly contagious skin disease that effects an estimated six million people in the United States, primarily children. Verrica is also currently exploring a Phase 3 program to study its injectable oncolytic peptide, VP-315, for the treatment of basal cell carcinoma, the most common form of skin cancer, and has initiated a global Phase 3 program to study VP-102 (YCANTH®) for the treatment of Common Warts. If you want to work in an environment that uses your unique skills and abilities in a fast-paced, small-pharma environment, we're the team for you!
POSITION SUMMARY
As an Inst...